Bedside percutaneous tracheostomy in acquired immunodeficiency syndrome

Area of Science:

• Medical procedures
• Critical care medicine
• Infectious diseases

Background:

• Patients with acquired immunodeficiency syndrome (AIDS) often require prolonged mechanical ventilation.
• Tracheostomy tube insertion is a common procedure for such patients.
• Conventional operating room tracheostomy carries risks and logistical challenges.

Purpose of the Study:

• To evaluate the safety and efficacy of bedside percutaneous tracheostomy in patients with AIDS.
• To compare bedside percutaneous tracheostomy with conventional operating room tracheostomy in this population.
• To assess the procedural benefits and patient outcomes.

Main Methods:

• Retrospective review of nine consecutive patients with AIDS undergoing percutaneous tracheostomy.
• Data collected on patient demographics, ventilation duration, procedure success, complications, and survival.
• Analysis of outcomes including in-hospital mortality and long-term survival.

Main Results:

• The procedure was successful and complication-free in all nine patients.
• In-hospital mortality was 77%, with an average survival of 29 days for those deceased.
• Two patients survived hospitalization after decannulation, with follow-up up to 42 months.

Conclusions:

• Bedside percutaneous tracheostomy is a safe and efficient method for providing prolonged tracheal access in AIDS patients.
• This technique reduces procedural costs, eliminates patient transport, and minimizes risks to staff.
• Despite poor prognosis, the procedure can improve patient comfort and oral care.